Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,027 | 60 | 99.5% |
| Education | $5.40 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $535.80 | 34 | $0 (2024) |
| Lilly USA, LLC | $110.96 | 5 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $94.83 | 5 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $84.79 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $38.21 | 2 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $37.73 | 2 | $0 (2022) |
| Allergan, Inc. | $37.44 | 2 | $0 (2020) |
| Esperion Therapeutics, Inc. | $34.29 | 2 | $0 (2022) |
| Shire North American Group Inc | $21.19 | 1 | $0 (2019) |
| IDORSIA PHARMACEUTICALS US INC | $18.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.06 | 1 | AstraZeneca Pharmaceuticals LP ($16.06) |
| 2023 | $106.71 | 5 | AstraZeneca Pharmaceuticals LP ($58.48) |
| 2022 | $153.59 | 8 | Lilly USA, LLC ($81.57) |
| 2021 | $51.85 | 3 | Merck Sharp & Dohme Corporation ($19.87) |
| 2020 | $94.55 | 5 | Merck Sharp & Dohme Corporation ($40.78) |
| 2019 | $170.34 | 11 | AstraZeneca Pharmaceuticals LP ($73.72) |
| 2018 | $203.75 | 14 | AstraZeneca Pharmaceuticals LP ($158.30) |
| 2017 | $235.32 | 14 | AstraZeneca Pharmaceuticals LP ($180.57) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
| 11/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: INSOMNIA | ||||||
| 12/22/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/16/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: PSYCHOLOGY | ||||||
| 09/14/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Neuroscience | ||||||
| 08/03/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Neuroscience | ||||||
| 06/22/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: PSYCHOLOGY | ||||||
| 05/04/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/13/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Neuroscience | ||||||
| 03/02/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Neuroscience | ||||||
| 03/03/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Respiratory | ||||||
| 01/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: Cardiovascular | ||||||
| 08/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 602 | 1,075 | $113,554 | $67,102 |
| 2022 | 13 | 579 | 1,130 | $114,442 | $68,434 |
| 2021 | 13 | 554 | 1,005 | $103,900 | $63,638 |
| 2020 | 12 | 472 | 926 | $91,108 | $53,249 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 400 | $48,025 | $26,205 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 206 | $34,619 | $21,175 | 61.2% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 83 | 83 | $11,669 | $6,831 | 58.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $4,752 | $3,274 | 68.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $3,150 | $3,021 | 95.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,800 | $1,619 | 90.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 14 | 14 | $3,233 | $1,606 | 49.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 93 | 181 | $2,715 | $1,520 | 56.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 14 | 14 | $1,645 | $912.61 | 55.5% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2023 | 21 | 22 | $969.85 | $421.26 | 43.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 32 | $715.11 | $370.44 | 51.8% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 14 | 14 | $259.68 | $146.40 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 419 | $39,936 | $24,718 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 209 | $29,202 | $20,363 | 69.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $10,050 | $5,211 | 51.9% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2022 | 63 | 64 | $10,020 | $4,843 | 48.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 15 | 87 | $10,199 | $3,984 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 21 | $3,904 | $3,085 | 79.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 32 | $2,400 | $2,187 | 91.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 37 | $1,442 | $1,282 | 88.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,657 | $1,198 | 72.3% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2022 | 30 | 31 | $1,713 | $573.03 | 33.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 144 | $2,160 | $426.45 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 28 | $859.98 | $336.84 | 39.2% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 11 | 12 | $900.00 | $226.84 | 25.2% |
About Dr. Steven Linzer, DO
Dr. Steven Linzer, DO is a Family Medicine healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356326193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Linzer, DO has received a total of $1,032 in payments from pharmaceutical and medical device companies, with $16.06 received in 2024. These payments were reported across 61 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,027).
As a Medicare-enrolled provider, Linzer has provided services to 2,207 Medicare beneficiaries, totaling 4,136 services with total Medicare billing of $252,422. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location East Meadow, NY
- Active Since 12/14/2005
- Last Updated 08/30/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356326193
Products in Payments
- FARXIGA (Drug) $344.66
- BEVESPI AEROSPHERE (Drug) $109.50
- JANUVIA (Drug) $94.83
- Livalo (Drug) $84.79
- EMGALITY (Drug) $81.57
- SYMBICORT (Drug) $51.69
- ADVAIR (Drug) $38.21
- QELBREE (Drug) $37.73
- UBRELVY (Drug) $37.08
- NEXLETOL (Drug) $34.29
- JARDIANCE (Drug) $29.39
- VYVANSE (Drug) $21.19
- QUVIVIQ (Drug) $18.84
- BYSTOLIC (Drug) $18.45
- AIRSUPRA (Drug) $16.06
- BREZTRI (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Meadow
Dr. Jeffrey Caruso, D.o, D.O
Family Medicine — Payments: $3,981
Dr. Sebeen Razzaq-Ahmed, D.o, D.O
Family Medicine — Payments: $398.97
Smiley Sharma, Do, DO
Family Medicine — Payments: $347.10
Dr. Christopher Calapai, D.o, D.O
Family Medicine — Payments: $150.00
Aliza Raza, D.o, D.O
Family Medicine — Payments: $91.80
Dr. Ramzi Farhat, Do, DO
Family Medicine — Payments: $49.80